Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences Net Income 2010-2025 | GILD

Gilead Sciences annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Gilead Sciences net income for the quarter ending March 31, 2025 was $1.315B, a 131.53% decline year-over-year.
  • Gilead Sciences net income for the twelve months ending March 31, 2025 was $5.965B, a 1129.9% increase year-over-year.
  • Gilead Sciences annual net income for 2024 was $0.48B, a 91.53% decline from 2023.
  • Gilead Sciences annual net income for 2023 was $5.665B, a 23.37% increase from 2022.
  • Gilead Sciences annual net income for 2022 was $4.592B, a 26.23% decline from 2021.
  
Gilead Sciences Annual Net Income
(Millions of US $)
2024 $480
2023 $5,665
2022 $4,592
2021 $6,225
2020 $123
2019 $5,386
2018 $5,455
2017 $4,628
2016 $13,501
2015 $18,108
2014 $12,101
2013 $3,075
2012 $2,592
2011 $2,804
2010 $2,901
2009 $2,636
Gilead Sciences Quarterly Net Income
(Millions of US $)
2025-03-31 $1,315
2024-12-31 $1,783
2024-09-30 $1,253
2024-06-30 $1,614
2024-03-31 $-4,170
2023-12-31 $1,430
2023-09-30 $2,180
2023-06-30 $1,045
2023-03-31 $1,010
2022-12-31 $1,640
2022-09-30 $1,789
2022-06-30 $1,144
2022-03-31 $19
2021-12-31 $382
2021-09-30 $2,592
2021-06-30 $1,522
2021-03-31 $1,729
2020-12-31 $1,551
2020-09-30 $360
2020-06-30 $-3,339
2020-03-31 $1,551
2019-12-31 $2,696
2019-09-30 $-1,165
2019-06-30 $1,880
2019-03-31 $1,975
2018-12-31 $3
2018-09-30 $2,097
2018-06-30 $1,817
2018-03-31 $1,538
2017-12-31 $-3,865
2017-09-30 $2,718
2017-06-30 $3,073
2017-03-31 $2,702
2016-12-31 $3,108
2016-09-30 $3,330
2016-06-30 $3,497
2016-03-31 $3,566
2015-12-31 $4,683
2015-09-30 $4,600
2015-06-30 $4,492
2015-03-31 $4,333
2014-12-31 $3,487
2014-09-30 $2,731
2014-06-30 $3,656
2014-03-31 $2,227
2013-12-31 $792
2013-09-30 $789
2013-06-30 $773
2013-03-31 $722
2012-12-31 $763
2012-09-30 $676
2012-06-30 $712
2012-03-31 $442
2011-12-31 $665
2011-09-30 $741
2011-06-30 $746
2011-03-31 $651
2010-12-31 $629
2010-09-30 $705
2010-06-30 $712
2010-03-31 $855
2009-12-31 $802
2009-09-30 $673
2009-06-30 $571
2009-03-31 $589
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $129.098B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $224.654B 16.77
Amgen (AMGN) US $151.198B 13.55
Vertex Pharmaceuticals (VRTX) US $128.836B 0.00
Bristol Myers Squibb (BMY) US $102.914B 6.89
GSK (GSK) GB $80.610B 9.58
CSL (CSLLY) AU $80.379B 0.00
Regeneron Pharmaceuticals (REGN) US $66.208B 15.87
Argenex SE (ARGX) NL $39.669B 272.97
Alnylam Pharmaceuticals (ALNY) US $33.821B 0.00
BeiGene (ONC) KY $25.298B 0.00
BioNTech SE (BNTX) DE $25.183B 0.00
Biogen (BIIB) US $18.101B 7.81
Genmab (GNMSF) DK $14.542B 14.98
Genmab (GMAB) DK $13.773B 17.32
Insmed (INSM) US $13.146B 0.00
Illumina (ILMN) US $12.326B 31.79
Incyte (INCY) US $12.104B 91.96
BioMarin Pharmaceutical (BMRN) US $11.836B 19.32
Exelixis (EXEL) US $10.913B 22.63
Swedish Orphan Biovitrum (BIOVF) SE $10.858B 27.73
Moderna (MRNA) US $10.678B 0.00
Ascendis Pharma (ASND) DK $10.491B 0.00
Exact Sciences (EXAS) US $9.724B 0.00
QIAGEN (QGEN) NL $9.587B 19.30
Roivant Sciences (ROIV) GB $8.192B 0.00
Bio-Techne Corp (TECH) US $7.982B 30.60
Repligen (RGEN) US $7.946B 89.00
Revolution Medicines (RVMD) US $7.585B 0.00
Halozyme Therapeutics (HALO) US $7.559B 15.61
Jazz Pharmaceuticals (JAZZ) IE $7.399B 6.59
TG Therapeutics (TGTX) US $6.897B 310.29
Blueprint Medicines (BPMC) US $6.758B 0.00
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Telix Pharmaceuticals (TLX) AU $6.318B 0.00
Sarepta Therapeutics (SRPT) US $6.240B 29.00
Verona Pharma American Depositary Share (VRNA) GB $6.181B 0.00
Legend Biotech (LEGN) US $6.092B 0.00
Guardant Health (GH) US $5.804B 0.00
ADMA Biologics Inc (ADMA) US $5.589B 47.04
Nuvalent (NUVL) US $5.546B 0.00
Axsome Therapeutics (AXSM) US $5.523B 0.00
Zealand Pharma (ZLDPF) DK $5.337B 0.00
Alkermes (ALKS) IE $5.241B 14.06
Krystal Biotech (KRYS) US $4.802B 50.05
Vaxcyte (PCVX) US $4.565B 0.00
Cytokinetics (CYTK) US $4.452B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.071B 0.00
PTC Therapeutics (PTCT) US $3.958B 0.00
Avidity Biosciences (RNA) US $3.881B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.690B 0.00
Arcellx (ACLX) US $3.610B 0.00
Akero Therapeutics (AKRO) US $3.575B 0.00
SpringWorks Therapeutics (SWTX) US $3.467B 0.00
Zai Lab (ZLAB) CN $3.440B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.303B 0.00
Viking Therapeutics (VKTX) US $3.297B 0.00
Scholar Rock Holding (SRRK) US $3.122B 0.00
Merus (MRUS) NL $3.057B 0.00
Xenon Pharmaceuticals (XENE) CA $2.932B 0.00
Protagonist Therapeutics (PTGX) US $2.820B 10.84
MoonLake Immunotherapeutics (MLTX) CH $2.709B 0.00
Metsera (MTSR) US $2.695B 0.00
Immunovant (IMVT) US $2.684B 0.00
HUTCHMED (China) (HCM) HK $2.615B 0.00
Apellis Pharmaceuticals (APLS) US $2.556B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.495B 22.25
Alvotech (ALVO) LU $2.478B 0.00
Denali Therapeutics (DNLI) US $2.388B 0.00
Twist Bioscience (TWST) US $2.341B 0.00
Biohaven (BHVN) US $2.332B 0.00
Kymera Therapeutics (KYMR) US $2.297B 0.00
ImmunityBio (IBRX) US $2.242B 0.00
Ascentage Pharma Group - (AAPG) CN $2.219B 0.00
CG Oncology (CGON) US $2.214B 0.00
Mirum Pharmaceuticals (MIRM) US $2.161B 0.00
Ligand Pharmaceuticals (LGND) US $2.109B 0.00
Certara (CERT) US $2.098B 44.79
Amicus Therapeutics (FOLD) US $2.054B 222.33
Beam Therapeutics (BEAM) US $2.035B 0.00
NovoCure (NVCR) JE $2.023B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.009B 0.00
Belite Bio (BLTE) US $1.995B 0.00
Tarsus Pharmaceuticals (TARS) US $1.990B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.980B 0.00
Vericel (VCEL) US $1.953B 216.39
Janux Therapeutics (JANX) US $1.945B 0.00
Bavarian Nordic (BVNRY) DK $1.897B 13.37
Travere Therapeutics (TVTX) US $1.878B 0.00
IDEAYA Biosciences (IDYA) US $1.833B 0.00
Arcutis Biotherapeutics (ARQT) US $1.817B 0.00
Apogee Therapeutics (APGE) US $1.801B 0.00
Edgewise Therapeutics (EWTX) US $1.772B 0.00
Agios Pharmaceuticals (AGIO) US $1.743B 0.00
Harmony Biosciences Holdings (HRMY) US $1.740B 12.08
Disc Medicine (IRON) US $1.712B 0.00
Vera Therapeutics (VERA) US $1.613B 0.00
ANI Pharmaceuticals (ANIP) US $1.588B 17.97
Structure Therapeutics (GPCR) US $1.553B 0.00
Mesoblast (MESO) AU $1.540B 0.00
Immunocore Holdings (IMCR) GB $1.525B 0.00
MannKind (MNKD) US $1.519B 31.25
Adaptive Biotechnologies (ADPT) US $1.495B 0.00
Dynavax Technologies (DVAX) US $1.387B 62.94
Celldex Therapeutics (CLDX) US $1.372B 0.00
Liquidia Technologies (LQDA) US $1.353B 0.00
89BIO (ETNB) US $1.274B 0.00
GRAIL (GRAL) US $1.263B 0.00
WAVE Life Sciences (WVE) SG $1.248B 0.00
Pacira BioSciences (PCRX) US $1.224B 11.50
Syndax Pharmaceuticals (SNDX) US $1.181B 0.00
Iovance Biotherapeutics (IOVA) US $1.169B 0.00
BGM Group (BGM) CN $1.138B 0.00
Viridian Therapeutics (VRDN) US $1.111B 0.00
Novavax (NVAX) US $1.031B 0.00
Mineralys Therapeutics (MLYS) US $1.000B 0.00
NeoGenomics (NEO) US $0.991B 0.00
Arcus Biosciences (RCUS) US $0.966B 0.00
Pharvaris (PHVS) NL $0.961B 0.00
MiMedx (MDXG) US $0.933B 22.57
Anbio Biotechnology (NNNN) DE $0.925B 0.00
Intellia Therapeutics (NTLA) US $0.916B 0.00
Spyre Therapeutics (SYRE) US $0.911B 0.00
Zymeworks (ZYME) US $0.902B 0.00
Geron (GERN) US $0.879B 0.00
Gyre Therapeutics (GYRE) US $0.868B 115.75
Nurix Therapeutics (NRIX) US $0.859B 0.00
Rocket Pharmaceuticals (RCKT) US $0.855B 0.00
Vir Biotechnology (VIR) US $0.850B 0.00
Nuvation Bio (NUVB) US $0.833B 0.00
Oculis Holding AG (OCS) CH $0.824B 0.00
Praxis Precision Medicines (PRAX) US $0.820B 0.00
LENZ Therapeutics (LENZ) US $0.813B 0.00
UniQure (QURE) NL $0.809B 0.00
Day One Biopharmaceuticals (DAWN) US $0.804B 0.00
Anavex Life Sciences (AVXL) US $0.799B 0.00
CureVac (CVAC) DE $0.799B 4.34
Regencell Bioscience Holdings (RGC) HK $0.797B 0.00
Bicara Therapeutics (BCAX) US $0.791B 0.00
Replimune (REPL) US $0.771B 0.00
Immunome (IMNM) US $0.770B 0.00
ArriVent BioPharma (AVBP) US $0.725B 0.00
AbCellera Biologics (ABCL) CA $0.719B 0.00
Trevi Therapeutics (TRVI) US $0.698B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Myriad Genetics (MYGN) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.687B 0.00
Cogent Biosciences (COGT) US $0.668B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Bicycle Therapeutics (BCYC) GB $0.644B 0.00
CorMedix Inc (CRMD) US $0.636B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.636B 0.00
Immatics (IMTX) DE $0.636B 37.36
Niagen Bioscience (NAGE) US $0.629B 200.00
AnaptysBio (ANAB) US $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Pharming Group (PHAR) NL $0.610B 0.00
Sionna Therapeutics (SION) US $0.599B 0.00
Keros Therapeutics (KROS) US $0.595B 0.00
GH Research (GHRS) IE $0.593B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Tyra Biosciences (TYRA) US $0.577B 0.00
Fortrea Holdings (FTRE) US $0.567B 18.41
Arvinas (ARVN) US $0.563B 0.00
Kura Oncology (KURA) US $0.560B 0.00
Castle Biosciences (CSTL) US $0.558B 31.21
Urogen Pharma (URGN) US $0.531B 0.00
Stoke Therapeutics (STOK) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Mind Medicine (MindMed) (MNMD) US $0.522B 0.00
REGENXBIO (RGNX) US $0.521B 0.00
Cullinan Therapeutics (CGEM) US $0.519B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.502B 0.00
Zenas BioPharma (ZBIO) US $0.499B 0.00
Cytek Biosciences (CTKB) US $0.493B 0.00
Maze Therapeutics (MAZE) US $0.475B 0.00
Eton Pharmaceuticals (ETON) US $0.465B 0.00
Upstream Bio (UPB) US $0.464B 0.00
Precigen (PGEN) US $0.463B 0.00
Prothena (PRTA) IE $0.458B 0.00
Sage Therapeutics (SAGE) US $0.457B 0.00
Abivax SA (ABVX) FR $0.456B 0.00
Erasca (ERAS) US $0.448B 0.00
Northwest Biotherapeutics (NWBO) US $0.432B 0.00
Sana Biotechnology (SANA) US $0.426B 0.00
Mereo BioPharma Group - (MREO) GB $0.425B 0.00
PureTech Health (PRTC) US $0.422B 0.00
Oxford BioMedica (OXBDF) GB $0.416B 0.00
Rapport Therapeutics (RAPP) US $0.414B 0.00
Celcuity (CELC) US $0.412B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.409B 0.00
Tectonic Therapeutic (TECX) US $0.406B 0.00
Oric Pharmaceuticals (ORIC) US $0.403B 0.00
MBX Biosciences (MBX) US $0.401B 0.00
Absci (ABSI) US $0.386B 0.00
Olema Pharmaceuticals (OLMA) US $0.384B 0.00
Kamada (KMDA) IL $0.383B 25.61
Verastem (VSTM) US $0.383B 0.00
Allogene Therapeutics (ALLO) US $0.372B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Benitec Biopharma (BNTC) US $0.353B 0.00
Entrada Therapeutics (TRDA) US $0.350B 4.83
Alpha Teknova (TKNO) US $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.348B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Solid Biosciences (SLDB) US $0.334B 0.00
Septerna (SEPN) US $0.333B 0.00
Cartesian Therapeutics (RNAC) US $0.329B 0.00
Abeona Therapeutics (ABEO) US $0.320B 0.00
ATyr Pharma (ATYR) US $0.320B 0.00
Aura Biosciences (AURA) US $0.309B 0.00
Monte Rosa Therapeutics (GLUE) US $0.306B 0.00
Terns Pharmaceuticals (TERN) US $0.306B 0.00
Fulcrum Therapeutics (FULC) US $0.303B 0.00
Astria Therapeutics (ATXS) US $0.302B 0.00
MaxCyte (MXCT) US $0.300B 0.00
ITeos Therapeutics (ITOS) US $0.297B 0.00
XOMA Royalty (XOMA) US $0.291B 0.00
Emergent Biosolutions (EBS) US $0.279B 0.00
Aardvark Therapeutics (AARD) US $0.279B 0.00
Monopar Therapeutics (MNPR) US $0.275B 0.00
Cidara Therapeutics (CDTX) US $0.272B 0.00
Palvella Therapeutics (PVLA) US $0.270B 0.00
Lifecore Biomedical (LFCR) US $0.270B 0.00
Vanda Pharmaceuticals (VNDA) US $0.269B 0.00
Gossamer Bio (GOSS) US $0.268B 0.00
2seventy Bio (TSVT) US $0.266B 0.00
Design Therapeutics (DSGN) US $0.264B 0.00
Compass Therapeutics (CMPX) US $0.261B 0.00
Candel Therapeutics (CADL) US $0.260B 0.00
ACELYRIN, INC (SLRN) US $0.259B 0.00
Atea Pharmaceuticals (AVIR) US $0.255B 0.00
Kodiak Sciences (KOD) US $0.253B 0.00
Prima BioMed (IMMP) AU $0.250B 0.00
Corvus Pharmaceuticals (CRVS) US $0.247B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.246B 0.00
DBV Technologies S.A (DBVT) FR $0.245B 0.00
Rezolute (RZLT) US $0.242B 0.00
Neurogene (NGNE) US $0.242B 0.00
Foghorn Therapeutics (FHTX) US $0.236B 0.00
BioStem Technologies (BSEM) $0.234B 9.35
Third Harmonic Bio (THRD) US $0.233B 0.00
Bright Minds Biosciences (DRUG) US $0.227B 0.00
Amarin (AMRN) IE $0.226B 0.00
Ocugen (OCGN) US $0.223B 0.00
Prime Medicine (PRME) US $0.220B 0.00
Nuvectis Pharma (NVCT) US $0.218B 0.00
Alumis (ALMS) US $0.217B 0.00
Annexon (ANNX) US $0.216B 0.00
GENFIT S.A (GNFT) FR $0.214B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.213B 0.00
ProQR Therapeutics (PRQR) NL $0.209B 0.00
Codexis (CDXS) US $0.209B 0.00
Actuate Therapeutics (ACTU) US $0.206B 0.00
Humacyte (HUMA) US $0.203B 0.00
Voyager Therapeutics (VYGR) US $0.201B 0.00
Y-mAbs Therapeutics (YMAB) US $0.200B 0.00
CARGO Therapeutics (CRGX) US $0.199B 0.00
Eledon Pharmaceuticals (ELDN) US $0.198B 0.00
EnGene Holdings (ENGN) CA $0.195B 0.00
Phathom Pharmaceuticals (PHAT) US $0.193B 0.00
Innate Pharma S.A (IPHA) FR $0.189B 0.00
Cardiff Oncology (CRDF) US $0.188B 0.00
Semper Paratus Acquisition (TVGN) US $0.186B 0.00
DiaMedica Therapeutics (DMAC) US $0.181B 0.00
INmune Bio (INMB) US $0.178B 0.00
Inventiva S.A (IVA) FR $0.177B 0.00
Inhibrx Biosciences (INBX) US $0.176B 0.00
Adherex Technologies (FENC) US $0.174B 0.00
AC Immune (ACIU) CH $0.173B 0.00
TuHURA Biosciences (HURA) US $0.171B 0.00
Sangamo Therapeutics (SGMO) US $0.167B 0.00
Molecular Partners AG (MOLN) CH $0.165B 0.00
Galena Biopharma (SLS) US $0.165B 0.00
Tango Therapeutics (TNGX) US $0.163B 0.00
Puma Biotechnology (PBYI) US $0.159B 5.26
BioAge Labs (BIOA) US $0.150B 0.00
Fate Therapeutics (FATE) US $0.150B 0.00
Tiziana Life Sciences (TLSA) GB $0.150B 0.00
Nkarta (NKTX) US $0.148B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.144B 0.00
ADC Therapeutics SA (ADCT) CH $0.143B 0.00
Editas Medicine (EDIT) US $0.137B 0.00
Vigil Neuroscience (VIGL) US $0.135B 0.00
Greenwich LifeSciences (GLSI) US $0.133B 0.00
Compugen (CGEN) IL $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.131B 0.00
Alector (ALEC) US $0.130B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.128B 0.00
Rapt Therapeutics (RAPT) US $0.128B 0.00
Coherus BioSciences (CHRS) US $0.128B 0.00
Theratechnologies (THTX) CA $0.127B 0.00
Neumora Therapeutics (NMRA) US $0.126B 0.00
C4 Therapeutics (CCCC) US $0.124B 0.00
Seer (SEER) US $0.123B 0.00
Sagimet Biosciences (SGMT) US $0.117B 0.00
InflaRx (IFRX) DE $0.116B 0.00
Immunic (IMUX) US $0.110B 0.00
BioHarvest Sciences (BHST) CA $0.107B 0.00
Entera Bio (ENTX) IL $0.107B 0.00
Coya Therapeutics (COYA) US $0.107B 0.00
Contineum Therapeutics (CTNM) US $0.106B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Inozyme Pharma (INZY) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Pliant Therapeutics (PLRX) US $0.104B 0.00
Ventyx Biosciences (VTYX) US $0.103B 0.00
Alpha Cognition (ACOG) CA $0.102B 0.00
Black Diamond Therapeutics (BDTX) US $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Genelux (GNLX) US $0.099B 0.00
Kyverna Therapeutics (KYTX) US $0.099B 0.00
HilleVax (HLVX) US $0.098B 0.00
Instil Bio (TIL) US $0.095B 0.00
Sutro Biopharma (STRO) US $0.093B 0.00
EXoZymes (EXOZ) US $0.091B 0.00
TScan Therapeutics (TCRX) US $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
CervoMed (CRVO) US $0.089B 0.00
XBiotech (XBIT) US $0.089B 0.00
Cellectis S.A (CLLS) FR $0.088B 0.00
Elicio Therapeutics (ELTX) US $0.088B 0.00
Senti Biosciences (SNTI) US $0.087B 0.00
Climb Bio (CLYM) US $0.086B 0.00
Nautilus Biotechnology (NAUT) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.084B 0.00
Elutia (ELUT) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Biomea Fusion (BMEA) US $0.082B 0.00
Caribou Biosciences (CRBU) US $0.082B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.081B 0.00
I-Mab (IMAB) US $0.077B 0.00
Invivyd (IVVD) US $0.075B 0.00
MediciNova (MNOV) US $0.074B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.074B 0.00
Adverum Biotechnologies (ADVM) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
Adagene (ADAG) CN $0.072B 0.00
VTv Therapeutics (VTVT) US $0.072B 0.00
Adlai Nortye (ANL) KY $0.071B 0.00
Inovio Pharmaceuticals (INO) US $0.070B 0.00
Milestone Pharmaceuticals (MIST) CA $0.070B 0.00
Skye Bioscience (SKYE) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.069B 0.00
BeyondSpring (BYSI) US $0.068B 0.00
Cabaletta Bio (CABA) US $0.068B 0.00
Exicure (XCUR) US $0.068B 0.00
Clearside Biomedical (CLSD) US $0.067B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Citius Oncology (CTOR) US $0.066B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Agenus (AGEN) US $0.066B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Applied Therapeutics (APLT) US $0.065B 0.00
Prenetics Global (PRE) HK $0.065B 0.00
CytomX Therapeutics (CTMX) US $0.065B 2.11
PDS Biotechnology (PDSB) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
Repare Therapeutics (RPTX) CA $0.061B 0.00
Akoya Biosciences (AKYA) US $0.061B 0.00
Achilles Therapeutics (ACHL) GB $0.061B 0.00
Precision BioSciences (DTIL) US $0.061B 0.00
Ikena Oncology (IKNA) US $0.060B 0.00
Artiva Biotherapeutics (ARTV) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.059B 0.00
Immix Biopharma (IMMX) US $0.058B 0.00
Adicet Bio (ACET) US $0.055B 0.00
Fortress Biotech (FBIO) US $0.054B 0.00
Renovaro (RENB) US $0.053B 0.00
ZIVO Bioscience (ZIVO) US $0.053B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.052B 0.00
PepGen (PEPG) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Shattuck Labs (STTK) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.047B 0.00
Quince Therapeutics (QNCX) US $0.047B 0.00
Atara Biotherapeutics (ATRA) US $0.047B 0.00
Cue Biopharma (CUE) US $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Forte Biosciences (FBRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.046B 0.00
Tenaya Therapeutics (TNYA) US $0.046B 0.00
Immuneering (IMRX) US $0.045B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Kronos Bio (KRON) US $0.043B 0.00
Whitehawk Therapeutics (WHWK) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.042B 0.00
Estrella Immunopharma (ESLA) US $0.042B 0.00
Tvardi Therapeutics (TVRD) US $0.041B 0.00
Werewolf Therapeutics (HOWL) US $0.041B 0.00
TELA Bio (TELA) US $0.040B 0.00
Rein Therapeutics (RNTX) US $0.040B 0.00
CAMP4 Therapeutics (CAMP) US $0.039B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Bluebird Bio (BLUE) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.038B 0.00
Celularity (CELU) US $0.038B 0.00
Scilex Holding (SCLX) US $0.038B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
RenovoRx (RNXT) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.036B 0.00
Dyadic (DYAI) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Pluri (PLUR) IL $0.034B 0.00
Aligos Therapeutics (ALGS) US $0.034B 0.00
LAVA Therapeutics (LVTX) NL $0.034B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Kezar Life Sciences (KZR) US $0.033B 0.00
BioAtla (BCAB) US $0.033B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Radiopharm Theranostics - (RADX) AU $0.031B 0.00
Grace Therapeutics (GRCE) CA $0.031B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
MiNK Therapeutics (INKT) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Kalaris Therapeutics (KLRS) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
Passage Bio (PASG) US $0.025B 0.00
CalciMedica (CALC) US $0.024B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.023B 0.00
Annovis Bio (ANVS) US $0.023B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
Quantum Biopharma (QNTM) CA $0.021B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Lexaria Bioscience (LEXX) CA $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.021B 0.00
Curis (CRIS) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
Q32 Bio (QTTB) US $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Allarity Therapeutics (ALLR) US $0.019B 0.00
ABVC BioPharma (ABVC) US $0.018B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Gelteq (GELS) AU $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
Aspire Biopharma Holdings (ASBP) US $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
Affimed (AFMD) DE $0.015B 0.00
GeoVax Labs (GOVX) US $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
SAB Biotherapeutics (SABS) US $0.015B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Synlogic (SYBX) US $0.014B 0.00
Biorestorative Therapies (BRTX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
BioCardia (BCDA) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.014B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.013B 0.00
NextCure (NXTC) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
LakeShore Biopharma (LSB) CN $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Sensei Biotherapeutics (SNSE) US $0.011B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
BioAffinity Technologies (BIAF) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
GENPREX (GNPX) US $0.007B 0.00
Apollomics (APLM) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
180 Life Sciences (ATNF) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Adial Pharmaceuticals (ADIL) US $0.004B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Ensysce Biosciences (ENSC) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Titan Pharmaceuticals (TTNP) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
NAYA Biosciences (IVF) US $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00